On the 25th of last month, the AstraZeneca COVID-19 vaccine was being transported at Ulsan Nam-gu Public Health Center. [Yonhap News]

On the 25th of last month, the AstraZeneca COVID-19 vaccine was being transported at Ulsan Nam-gu Public Health Center. [Yonhap News]

View original image


[Asia Economy Yeongnam Reporting Headquarters Reporter Kim Yong-woo] The first suspected case of anaphylaxis has occurred in Ulsan. Additionally, three more cases of chain infection originating from a sauna have been confirmed, bringing the total to 47.


According to Ulsan city health authorities on the 15th, a female worker in her 30s at a hospital in Jung-gu who received the AstraZeneca (AZ) vaccine at around 2:30 PM on the 12th experienced symptoms such as difficulty breathing and hives within two hours after vaccination.


The woman showed a 'positive anaphylaxis reaction' and was hospitalized, but her symptoms improved on the same day and she was discharged.


Ulsan city announced that as of 5 PM on the 14th, a total of 301 cases have been reported as adverse reactions to the vaccine.


On the 15th in Ulsan, three additional confirmed COVID-19 cases (Ulsan numbers 1093 to 1095) related to chain infections originating from a sauna were reported.



All three are family members of previously confirmed cases linked to Hero Spa in Buk-gu and tested positive during self-quarantine. The cumulative number of confirmed cases originating from the Ulsan sauna has increased to 47.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing